The Effect of the Frequently Used Cinacalcet for pHPT during the COVID-19 Pandemic on Perioperative Decrease in Parathyroid Hormone

Background: Cinacalcet is a calcimimetic drug that has increasingly been used as a bridging therapy for primary hyperparathyroidism (pHPT), especially during the COVID-19 pandemic. The aim of our study was to investigate if preoperative cinacalcet therapy affects intraoperative parathyroid hormone (...

Descripción completa

Detalles Bibliográficos
Autores principales: Radulova-Mauersberger, Olga, Keßler, Julia, Keßler, Ulrich, Stange, Katrin, Korn, Sandra, Weitz, Jürgen, Bork, Ulrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000147/
https://www.ncbi.nlm.nih.gov/pubmed/35407623
http://dx.doi.org/10.3390/jcm11072015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000147/
https://www.ncbi.nlm.nih.gov/pubmed/35407623
http://dx.doi.org/10.3390/jcm11072015

Ejemplares similares